GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 27.78
-1.29 (-4.45%)
Oct 22, 2026, 4:00 PM EDT
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 11.37 billion as of October 22, 2026. It is the 7,266th most valuable company in the world and the 1,356th biggest in China. Its market cap has increased by 66.32% in one year.
Market Cap
11.37B
Enterprise Value
10.44B
Revenue
878.13M
Global Rank
Country Rank
#1,356 China
PE Ratio
61.51
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 11.37B, an increase of 49.85%. That is a compound annual growth rate of 9.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 11.37B | 80.49% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HitGen | 15.10B |
| BrightGene Bio-Medical Technology | 13.80B |
| Sino Biological,Inc. | 13.73B |
| Jinyu Bio-technology | 13.60B |
| Anhui Anke Biotechnology (Group) | 13.39B |
| Nanjing Vazyme Biotech | 11.91B |
| Hualan Biological Vaccine | 11.26B |
| Shanghai Medicilon | 11.03B |